Metal-N-heterocyclic carbene complexes as anti-tumor agents.

Chunqi Hu, Xin Li, Wei Wang, Ruoyu Zhang, Liping Deng

Journal: Current medicinal chemistry 2014;21(10):1220-30

PMID: 24350852

Abstract

It has been a long story of the development of anticancer metallopharmaceuticals since the identification of cisplatin. Advances in metallodrugs discovery during the past 40 years have made it an ever-growing area of research in medicinal inorganic chemistry. Meanwhile, the emerging of N-heterocyclic carbene (NHC) chemistry has stimulated the newly burgeoning interests in the biomedical applications of metal-NHC complexes. This review will detail what have been achieved hitherto in the research of metal-NHC complexes as potential anti-tumor agents coupled with gold, silver, copper, platinum and palladium. Their mechanism of action will also be discussed. All the results obtained indicate that this promising approach is worthy of more focuses and further studies.

Address: Department of Pharmacology, Chemistry and Chemical Engineering Institute, Shaoxing University, Shaoxing, Zhejiang 312000, China. [email protected].

DOI: 10.2174/0929867321666131217161849

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/24350852

Miscellaneous:

https://assays.cancer.gov/CPTAC-68

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Auranofin, Cell Line, Tumor, Cisplatin, Coordination Complexes, Copper, Gold, Heterocyclic Compounds, Humans, Methane, Neoplasms, Palladium, Platinum, Silver, Structure-Activity Relationship